Abnormal clock gene expression and locomotor activity rhythms in two month-old female APPSwe/PS1dE9 mice

Current Alzheimer Research

Volumn 14, Issue 8, 2017, Pages 850-860

  Oyegbami, Olaide ^a   Collins, Hilary M ^a   Pardon, Marie Christine ^a   Ebling, Francis J P ^a   Heery, David M ^a   Moran, Paula M ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Alzheimer s Disease; APPswe PS1dE9 mice; Bmal; Circadian; Clock genes; Cry1; Cry2; Per1; Per2; Rev Erb; Rev Erb

Indexed keywords

CRYPTOCHROME 1; CRYPTOCHROME 2; PER1 PROTEIN; PER2 PROTEIN; AMYLOID PRECURSOR PROTEIN; ARNTL PROTEIN, MOUSE; CIRCADIAN RHYTHM SIGNALING PROTEIN; CRY1 PROTEIN, MOUSE; CRY2 PROTEIN, MOUSE; CRYPTOCHROME; MESSENGER RNA; PER1 PROTEIN, MOUSE; PER2 PROTEIN, MOUSE; PRESENILIN 1; TRANSCRIPTION FACTOR ARNTL;

AGITATION; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CIRCADIAN RHYTHM; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENOTYPE; HIPPOCAMPUS; LOCOMOTION; MOUSE; NEUROPATHOLOGY; NONHUMAN; PONS; PRIORITY JOURNAL; SLEEP; TRANSGENIC MOUSE; ANIMAL; C57BL MOUSE; COMPLICATION; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHYSIOLOGY; TIME FACTOR;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; ARNTL TRANSCRIPTION FACTORS; CIRCADIAN RHYTHM; CRYPTOCHROMES; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION REGULATION; GENOTYPE; LOCOMOTION; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PERIOD CIRCADIAN PROTEINS; PRESENILIN-1; RNA, MESSENGER; TIME FACTORS;

EID: 85028968147     PISSN: 15672050     EISSN: 18755828     Source Type: Journal    
DOI: 10.2174/1567205014666170317113159     Document Type: Article

References (69)

1. Videnovic A, Lazar AS, Barker RA, Overeem S. The clocks that time us-circadian rhythms in neurodegenerative disorders. Nat Rev Neurol 10(12): 683-93 (2014).
2. Musiek ES, Xiong DD, Holtzman DM. Sleep, circadian rhythms, and the pathogenesis of Alzheimer disease. Exp Mol Med 47: e148 (2015).
3. Satlin A, Volicer L, Stopa EG, Harper D. Circadian locomotor activity and core-body temperature rhythms in Alzheimer's disease. Neurobiol Aging 16(5): 765-71 (1995).
4. Harper DG, Stopa EG, McKee AC, Satlin A, Harlan PC, Goldstein R, et al. Differential circadian rhythm disturbances in men with Alzheimer disease and frontotemporal degeneration. Arch Gen Psychiatry 58(4): 353-60 (2001).
5. Harper DG, Volicer L, Stopa EG, McKee AC, Nitta M, Satlin A. Disturbance of endogenous circadian rhythm in aging and Alzheimer disease. Am J Geriatr Psychiatry 13(5): 359-68 (2005).
6. Volicer L, Harper D, Manning B, Goldstein R, Satlin A. Sundowning and circadian rhythms in Alzheimer's disease. Am J Psychiatry 158(5): 704-11 (2001).
7. Guilding C, Piggins HD. Challenging the omnipotence of the suprachiasmatic timekeeper: are circadian oscillators present throughout the mammalian brain? Eur J Neurosci 25(11): 3195-216 (2007).
8. Reppert SM, Weaver DR. Coordination of circadian timing in mammals. Nature 418(6901): 935-41 (2002).
9. Barnard AR, Nolan PM. When clocks go bad: neurobehavioural consequences of disrupted circadian timing. PLoS Genet 4(5): e1000040 (2008).
10. Preitner N, Damiola F, Luis Lopez M, Zakany J, Duboule D, Albrecht U, et al. The orphan nuclear receptor REV-ERBݱ controls circadian transcription within the positive limb of the mammalian circadian oscillator. Cell 110(2): 251-60 (2002).
11. Nagoshi E, Saini C, Bauer C, Laroche T, Naef F, Schibler U. Circadian gene expression in individual fibroblasts: cell-autonomous and self-sustained oscillators pass time to daughter cells. Cell 119(5): 693-705 (2004).
12. Harbour VL, Weigl Y, Robinson B, Amir S. Comprehensive mapping of regional expression of the clock protein PERIOD2 in rat forebrain across the 24-h day. PLoS ONE 8(10): e76391 (2013).
13. Abe M, Herzog ED, Yamazaki S, Straume M, Tei H, Sakaki Y, et al. Circadian rhythms in isolated brain regions. J Neurosci 22(1): 350-6 (2002).
14. Stratmann K, Heinsen H, Korf HW, Del Turco D, Ghebremedhin E, Seidel K, et al. Precortical phase of Alzheimer's Disease (AD)-related tau cytoskeletal pathology. Brain Pathol 26(3): 371-86 (2016).
15. Duncan MJ, Smith JT, Franklin KM, Beckett TL, Murphy MP, St Clair DK, et al. Effects of aging and genotype on circadian rhythms, sleep, and clock gene expression in APPxPS1 knock-in mice, a model for Alzheimer's disease. Exp Neurol 236(2): 249-58 (2012).
16. Van Dam D, D'Hooge R, Staufenbiel M, Van Ginneken C, Van Meir F, De Deyn PP. Age-dependent cognitive decline in the APP23 model precedes amyloid deposition. Eur J Neurosci 17(2): 388-96 (2003).
17. Huitron-Resendiz S, Sanchez-Alavez M, Gallegos R, Berg G, Crawford E, Giacchino JL, et al. Age-independent and age-related deficits in visuospatial learning, sleep-wake states, thermoregulation and motor activity in PDAPP mice. Brain Res 928(1-2): 126-37 (2002).
18. Sterniczuk R, Dyck RH, LaFerla FM, Antle MC. Characterization of the 3xTg-AD mouse model of Alzheimer's disease: Part 1. Circadian changes. Brain Res 1348: 139-48 (2010).
19. Pugh PL, Richardson JC, Bate ST, Upton N, Sunter D. Noncognitive behaviours in an APP/PS1 transgenic model of Alzheimer's disease. Behav Brain Res 178(1): 18-28 (2007).
20. Van-Dam D, D'Hooge R, Staufenbiel M, VanGinneken C, Van-Meir F, DeDeyn PP. Age-dependent cognitive decline in the APP23 model precedes amyloid deposition. Eur J Neurosci 17(2): 388-96 (2003).
21. Pugh, Richardson JC, Bate ST, Upton N, Sunter D. Non-cognitive behaviours in an APP/PS1 transgenic model of Alzheimer's disease. Behav Brain Res 178(1): 18-28 (2007).
22. Bano-Otalora B, Popovic N, Gambini J, Popovic M, Vina J, Bonet-Costa V, et al. Circadian system functionality, hippocampal oxidative stress, and spatial memory in the APPswe/PS1dE9 transgenic model of alzheimer disease: effects of melatonin or ramelteon. Chronobiol Int 29: 822-34 (2012).
23. Gorman MR, Yellon S. Lifespan daily locomotor activity rhythms in a mouse model of amyloid-induced neuropathology. Chronobiol Int 27(6): 1159-77 (2010).
24. Sterniczuk R, Dyck RH, LaFerla FM, Antle MC. Characterization of the 3xTg-AD mouse model of Alzheimer's disease: Part 1. Circadian changes. Brain Res 1348: 139-48 (2010).
25. Abe M, Herzog ED, Yamazaki S, Straume M, Tei H, Sakaki Y, et al. Circadian rhythms in isolated brain regions. 22(1): 350-6 (2002).
26. Ono D, Honma K, Honma S. Circadian and ultradian rhythms of clock gene expression in the suprachiasmatic nucleus of freely moving mice. Sci Rep 5: 12310 (2015).
27. Yamaguchi Y, Okada K, Mizuno T, Ota T, Yamada H, Doi M, et al. Real-Time Recording of Circadian Per1 and Per2 Expression in the Suprachiasmatic Nucleus of Freely Moving Rats. J Biol Rhythms 31(1): 108-11 (2016).
28. Wang LMC, Dragich JM, Kudo T, Odom IH, Welsh DK, O'Dell TJ, et al. Expression of the circadian clock gene Period2 in the hippocampus: possible implications for synaptic plasticity and learned behaviour. ASN NEURO 1(3): e00012 (2009).
29. Wyse CA, Coogan AN. Impact of aging on diurnal expression patterns of CLOCK and BMAL1 in the mouse brain. Brain Res 1337: 21-31 (2010).
30. Duncan MJ, Prochot JR, Cook DH, Tyler Smith J, Franklin KM. Influence of aging on Bmal1 and Per2 expression in extra-SCN oscillators in hamster brain. Brain Res 1491: 44-53 (2013).
31. Chun LE, Woodruff ER, Morton S, Hinds LR, Spencer RL. Variations in phase and amplitude of rhythmic clock gene expression across prefrontal cortex, hippocampus, amygdala, and hypothalamic paraventricular and suprachiasmatic nuclei of male and female rats. J Biol Rhythms 30(5): 417-36 (2015).
32. Duncan MJ, Smith JT, Franklin KM, Beckett TL, Murphy MP, Clair DKS, et al. Effects of aging and genotype on circadian rhythms, sleep, and clock gene expression in APPxPS1 knock-in mice, a model for Alzheimer's disease. Exp Neurol 236(2): 249-58 (2010).
33. Jankowsky JL, Slunt HH, Ratovitski T, Jenkins NA, Copeland NG, Borchelt DR. Co-expression of multiple transgenes in mouse CNS: a comparison of strategies. Biomol Eng 17(6): 157-65 (2001).
34. Savonenko A, Xu GM, Melnikova T, Morton JL, Gonzales V, Wong MP, et al. Episodic-like memory deficits in the APPswe/ PS1dE9 mouse model of Alzheimer's disease: relationships to beta-amyloid deposition and neurotransmitter abnormalities. Neurobiol Dis 18(3): 602-17 (2005).
35. Bonardi C, de Pulford F, Jennings D, Pardon MC. A detailed analysis of the early context extinction deficits seen in APPswe/ PS1dE9 female mice and their relevance to preclinical Alzheimer's disease. Behav Brain Res 222(1): 89-97 (2011).
36. Maroof N, Ravipati S, Pardon MC, Barrett DA, Kendall DA. Reductions in endocannabinoid levels and enhanced coupling of cannabinoid receptors in the striatum are accompanied by cognitive impairments in the A beta PPswe/PS1 Delta E9 mouse model of Alzheimer's disease. J Alzheimers Dis 42(1): 227-45 (2014).
37. Refinetti R, Cornélissen G, Halberg F. Procedures for numerical analysis of circadian rhythms. Biol Rhythm Res 38: 275-325 (2007).
38. Refinetti R. Non-stationary time series and the robustness of circadian rhythms. J Theoretical Biol 227: 571-81 (2004).
39. Levine JD, Funes P, Dowse HB, Hall JC. Signal analysis of behavioral and molecular cycles. BMC Neurosci 3(1): (2002).
40. Huitrón-Reséndiz S, Sánchez-Alavez M, Gallegos R, Berg G, Crawford E, Giacchino JL, et al. Age-independent and age-related deficits in visuospatial learning, sleep-wake states, thermoregulation and motor activity in PDAPP mice. Brain Res 928: 126-37 (2002).
41. Vloeberghs E, Dam DV, Engelborghs S, Nagels G, Staufenbiel M, Deyn PPD. Altered circadian locomotor activity in APP23 mice: a model for BPSD disturbances. Eur J Neurosci 20(10): 2757-66 (2004).
42. Ambrée O, Touma C, Görtz N, Keyvani K, Paulus W, Palme R, et al. Activity changes and marked stereotypic behavior precede a pathology in TgCRND8 Alzheimer mice. Neurobiol Aging 27(7): 955-64 (2006).
43. Pittendrigh CS, Daan S. Functional-analysis of circadian pacemakers in nocturnal rodents.4. entrainment-pacemaker as clock. J Comp Physiol 106(3): 291-331 (1976).
44. Morin LP. Age-related-changes in hamster circadian period, entrainment, and rhythm splitting. J Biol Rhythms 3(3): 237-48 (1988).
45. Witting W, Mirmiran M, Bos NPA, Swaab DF. The effect of oldage on the free-running period of circadian-rhythms in rat. Chronobiol Intern 1(2): 103-12 (1994).
46. Welsh DK, Richardson GS, Dement WC. Effect of age on the circadian pattern of sleep and wakefulness in the mouse. J Gerontol 41(5): 579-86 (1986).
47. Valentinuzzi VS, Scarbrough K, Takahashi JS, Turek FW. Effects of aging on the circadian rhythm of wheel-running activity in C57BL/6 mice. Am J Physiol 273(6 Pt 2): R1957-64 (1997).
48. Volicer L, Harper DG, Manning BC, Goldstein R, Satlin A. Sundowning and circadian rhythms in Alzheimer's disease. Am J Psychiatry 158(5): 704-11 (2001).
49. Kume K, Zylka MJ, Sriram S, Shearman LP, Weaver DR, Jin X, et al. mCRY1 and mCRY2 are essential components of the negative limb of the circadian clock feedback loop. Cell 98(2): 193-205 (1999).
50. Chen C, Kuo T, Hsieh I, Yang C. Electrical stimulation of the rostral ventrolateral medulla promotes wakefulness in rats. Sleep Med 14(11): 1076-84 (2013).
51. Kalauzi A, Spasic S, Petrovic J, Ciric J. Cortico-pontine theta carrier frequency phase shift across sleep/wake states following monoaminergic lesion in rat. 31:163-71 (2012).
52. Bliwise DL, Carroll JS, Lee KA, Nekich JC, Dement WC. Sleep and "sundowning" in nursing home patients with dementia. Psychiatry Res 48(3): 277-92 (1993).
53. Nowak L, Davis JE. A qualitative examination of the phenomenon of sundowning. J Nurs Scholarship 39(3): 256-8 (2007).
54. Etchegaray JP, Lee C, Wade PA, Reppert SM. Rhythmic histone acetylation underlies transcription in the mammalian circadian clock. Nature 421(6919): 177-82 (2003).
55. Wang X, Wang L, Yu Q, Xu Y, Zhang L, Zhao X, et al. Alterations in the expression of Per1 and Per2 induced by Abeta31-35 in the suprachiasmatic nucleus, hippocampus, and heart of C57BL/6 mouse. Brain Res 1642: 51-8 (2016).
56. Valnegri P, Khelfaoui M, Dorseuil O, Bassani S, Lagneaux C, Gianfelice A, et al. A circadian clock in hippocampus is regulated by interaction between oligophrenin-1 and Rev-erb alpha. Nat Neurosci 14(10): 1293-U108 (2011).
57. Kaneko K, Yamada T, Tsukita S, Takahashi K, Ishigaki Y, Oka Y, et al. Obesity alters circadian expressions of molecular clock genes in the brainstem. Brain Res 1263: 58-68 (2009).
58. Baggs JE, Price TS, DiTacchio L, Panda S, FitzGerald GA, Hogenesch JB. Network features of the mammalian circadian clock. PLoS Biol 7(3): e1000052 (2009).
59. Wu Y-H, Fischer DF, Kalsbeek A, Garidou-Boof M-L, van der Vliet J, van Heijningen C, et al. Pineal clock gene oscillation is disturbed in Alzheimer's disease, due to functional disconnection from the "master clock". FASEB J 20(11): 1874-6 (2006).
60. Liu R-Y, Zhou J-N, van Heerikhuize J, Hofman MA, Swaab DF. Decreased melatonin levels in postmortem cerebrospinal fluid in relation to aging, Alzheimer's disease, and apolipoprotein Eepsilon4/ 4 genotype. J Clin Endocrinol Metabol 84(1): 323-7 (1999).
61. Skene DJ, Vivien-Roels B, Sparks DL, Hunsaker JC, Pãvet P, Ravid D, et al. Daily variation in the concentration of melatonin and 5-methoxytryptophol in the human pineal gland: effect of age and Alzheimer's disease. Brain Res 528(1): 170-4 (1990).
62. Jankowsky JL, Fadale DJ, Anderson J, Xu GM, Gonzales V, Jenkins NA, et al. Mutant presenilins specifically elevate the levels of the 42 residue B-amyloid peptide in vivo: evidence for augmentation of a 42-specific Gamma-secretase. Hum Mol Genet 13(2):159-70 (2004).
63. Garcia-Alloza M, Robbins EM, Zhang-Nunes SX, Purcell SM, Betensky RA, Raju S, et al. Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease. Neurobiol Dis 24(3): 516-24 (2006).
64. Volianskis A, Kostner R, Molgaard M, Hass S, Jensen MS. Episodic memory deficits are not related to altered glutamatergic synaptic transmission and plasticity in the CA1 hippocampus of the APPswe/PS1deltaE9-deleted transgenic mice model of ssamyloidosis. Neurobiol Aging 31(7): 1173-87 (2010).
65. Hu YS, Xu P, Pigino G, Brady ST, Larson J, Lazarov O. Complex environment experience rescues impaired neurogenesis, enhances synaptic plasticity, and attenuates neuropathology in familial Alzheimer's disease-linked APPswe/PS1 Delta E9 mice. Faseb J 24(6): 1667-81 (2010).
66. Busche MA, Eichhoff G, Adelsberger H, Abramowski D, Wiederhold KH, Haass C, et al. Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer's disease. Science 321(5896): 1686-9 (2008).
67. Busche MA, Chen XW, Henning HA, Reichwald J, Staufenbiel M, Sakmann B, et al. Critical role of soluble amyloid-beta for early hippocampal hyperactivity in a mouse model of Alzheimer's disease. Proc Nat Acad Sci USA 109(22): 8740-5 (2012).
68. Wang J, Tanila H, Puolivali J, Kadish I, van Groen T. Gender differences in the amount and deposition of amyloid beta in APPswe and PS1 double transgenic mice. Neurobiol Dis 14(3): 318-27 (2003).
69. Pistell PJ, Zhu M, Ingram DK. Acquisition of conditioned taste aversion is impaired in the amyloid precursor protein/presenilin 1 mouse model of Alzheimer's disease. Neuroscience 152(3): 594-600 (2008).